Scarica l'app Stockscreener
21.86
0.37%
0.08
Dopo l'orario di chiusura:
21.84
-0.02
-0.09%
Precedente Chiudi:
$21.78
Aprire:
$21.85
Volume 24 ore:
464.36K
Relative Volume:
2.57
Capitalizzazione di mercato:
$1.35B
Reddito:
-
Utile/perdita netta:
$-143.59M
Rapporto P/E:
-7.7419
EPS:
-2.8236
Flusso di cassa netto:
$-119.47M
1 W Prestazione:
-4.29%
1M Prestazione:
-8.19%
6M Prestazione:
+59.33%
1 anno Prestazione:
+1.67%
Intervallo 1D:
$21.57
$22.90
Intervallo di 1 settimana:
$20.70
$23.50
Portata 52W:
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
Confronta PHVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
21.86 | 1.35B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-09 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2025-06-11 | Iniziato | Guggenheim | Buy |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-09-25 | Iniziato | Wedbush | Outperform |
| 2023-08-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | Iniziato | Bryan Garnier | Buy |
| 2022-09-13 | Ripresa | JMP Securities | Mkt Outperform |
| 2022-08-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-05-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-03-02 | Iniziato | BofA Securities | Neutral |
| 2021-03-02 | Iniziato | Morgan Stanley | Overweight |
| 2021-03-02 | Iniziato | Oppenheimer | Outperform |
| 2021-03-02 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Pharvaris Nv Borsa (PHVS) Ultime notizie
Visual analytics tools that track Pharvaris N.V. performanceEarnings Risk Summary & Expert Curated Trade Ideas - newser.com
Can Pharvaris N.V. stock deliver sustainable ROEJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
How to escape a deep drawdown in Pharvaris N.V.Day Trade & Low Risk Investment Opportunities - newser.com
HC Wainwright & Co. Initiates Coverage of Pharvaris N.V. (PHVS) with Buy Recommendation - Nasdaq
HC Wainwright Initiates Coverage on Pharvaris N.V With Buy Rating, $60 Price Target - MarketScreener
PHVS: HC Wainwright & Co. Initiates Coverage with a "Buy" Rating - GuruFocus
Has Pharvaris N.V. found a price floorVolume Spike & Fast Exit Strategy with Risk Control - newser.com
Will earnings trigger a reversal in Pharvaris N.V.Risk Management & Daily Profit Maximizing Tips - newser.com
Will Pharvaris N.V. stock attract ESG investorsJuly 2025 Pullbacks & Verified Chart Pattern Signals - newser.com
Can Pharvaris N.V. stock sustain free cash flow growthJuly 2025 Reactions & Growth Focused Stock Reports - newser.com
What analyst consensus says on Pharvaris N.V. stockEarnings Recap Report & Capital Efficient Trade Techniques - newser.com
What data driven models say about Pharvaris N.V.’s futureJuly 2025 Final Week & Free Community Consensus Stock Picks - newser.com
What’s next for Pharvaris N.V. stock price2025 Trading Recap & AI Forecasted Entry/Exit Points - newser.com
Pharvaris (NASDAQ:PHVS) Upgraded at Bank of America - Defense World
Will Pharvaris N.V. (9EN) stock outperform benchmarksJuly 2025 Action & Verified Swing Trading Watchlist - newser.com
Pharvaris (NASDAQ:PHVS) Raised to Neutral at Bank of America - MarketBeat
Weiss Ratings Reiterates Sell (D-) Rating for Pharvaris (NASDAQ:PHVS) - MarketBeat
Chart based exit strategy for Pharvaris N.V.Market Movers & Verified Technical Signals - newser.com
B of A Securities Upgrades Pharvaris N.V. (PHVS) - Nasdaq
Building trade automation scripts for Pharvaris N.V.2025 Price Targets & Weekly High Return Stock Opportunities - newser.com
BofA Securities upgrades Pharvaris stock rating to Neutral on broader label potential By Investing.com - Investing.com South Africa
BofA Securities upgrades Pharvaris stock rating to Neutral on broader label potential - Investing.com Australia
Pharvaris NV (NASDAQ: PHVS) stock has achieved $25.44 in the past week - fostersleader.com
What drives Pharvaris NV stock priceHigh Yield Income Stocks & Fast Profit Trading Ideas - earlytimes.in
Is Pharvaris NV a good long term investmentTrendline Breakouts & Exceptional Return Stocks - earlytimes.in
Analyzing Pharvaris N.V. with multi timeframe chartsEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
How to forecast Pharvaris N.V. trends using time seriesTrade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Why pension funds invest in Pharvaris N.V. (9EN) stock2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
Combining price and volume data for Pharvaris N.V.July 2025 Breakouts & Weekly Watchlist of Top Performers - newser.com
Pharvaris (NASDAQ:PHVS) Shares Gap DownHere's What Happened - MarketBeat
Using Bollinger Bands to evaluate Pharvaris N.V.Share Buyback & Growth Focused Stock Reports - newser.com
Heatmap analysis for Pharvaris N.V. and competitors2025 Big Picture & Verified Entry Point Signals - newser.com
Is Pharvaris N.V. meeting your algorithmic filter criteria2025 Volatility Report & Risk Managed Investment Signals - newser.com
Is Pharvaris N.V. stock supported by strong cash flowsWeekly Trend Report & Low Risk High Reward Trade Ideas - newser.com
Pharvaris Nv Azioni (PHVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):